Address And Details

PO Box 2248 , Denver, CO 80201-2248
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The AQR Global Equity Fund (the Fund) seeks long-term capital appreciation. The Fund seeks to outperform, after expenses, the MSCI World Index (the Global Equity Benchmark) while seeking to control its tracking error relative to this benchmark. The Fund will target an average fore casted tracking error of approximately 4% relative to the Global Equity Benchmark over a long-term business cycle, but actual tracking error will vary based on market conditions, sector positioning, securities selection and other factors. The Global Equity Benchmark is a free float-adjusted market capitalization index that is designed to measure the performance of equities in developed markets, including the United States and Canada.

Net Asset Value

as of 6:11 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.92%
  • 1 Month
  • -0.09%
  • 3 Months
  • +2.08%
  • 1 Yr Return
  • +24.25%
  • 5 Yr Return
  • +36.32%

Equity Sector Breakdown

Technology 23.44%
Finance 15.19%
RetailTrade 14.71%
IndustrialCyclical 10.55%
NonDurables 4.29%
ConsumerDurables 3.09%
Services 2.81%
Health 2.07%
Utilities 2.02%
Energy 0.38%

Asset Allocation

Asset Type % Of Allocation
Stocks 86.44%
ForeignStocks 28.26%
Preferred 0.21%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 16.79 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -7.97 -5.72 -4.71
Beta 1.03 1.00 1.02
R Squared 0.95 0.91 0.90
Std Deviation 19.63 15.75 14.39
Sharpe Ratio 0.51 0.72 n/a

Purchase Information

as of 6:12 PM ET 09/16/2021
Minimum Initial $5000000
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +25.17%
  • +34.54%
+25.17% +34.54%
3 Year
  • +9.12%
  • +9.32%
+9.12% +9.32%
10 Year
  • +11.05%
  • +9.34%
+11.05% +9.34%
Life Of Fund
  • +9.84%
  • +9.75%
+9.84% +9.75%

Top 10 Holdings

Symbol Company Name % Of Assets
AAPL APPLE INC 4.54%
MSFT MICROSOFT CORP 3.25%
FB FACEBOOK INC 1.79%
WMT WALMART INC 1.44%
INTC INTEL CORP 1.44%
CSCO CISCO SYSTEMS INC 1.26%
AMZN AMAZON COM INC 1.24%
TGT TARGET CORP 1.23%
LMT LOCKHEED MARTIN CORP 1.22%
AD KONINKLIJKE AHOLD DELHAIZE NV 1.14%

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.